Clinical Trials in Houston

Showing 9781-9800 of 13,620 trials

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

NCT01762592

Study WX-20-002 will confirm diagnostic efficacy and safety of a PET/CT scan using Iodine (124I) Girentuximab performed during the diagnostic work-up in patients with indeterminate cT1-renal masses.

Renal Cell CarcinomaKidney Cancer

Heidelberg Pharma AGStarted Dec 2017

Los Angeles, California, United States • Tampa, Florida, United States • Burlington, Massachusetts, United States +5 more locations

COMPLETEDPhase 2< 1 mile

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

NCT01083602

This study is designed to assess the effectiveness of the combination of Panobinostat plus Bortezomib and Dexamethasone in patients with relapsed and bortezomib refractory Multiple Myeloma.

Relapsed and Bortezomib Refractory Multiple MyelomaRefractory Multiple MyelomaMultiple Myeloma in Relapse

Novartis Pharmaceuticals55 participantsStarted Jun 2010

Los Angeles, California, United States • Stanford, California, United States • Tampa, Florida, United States +10 more locations

REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

Find Trials by Condition in Houston

Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Safety and Efficacy Trial of Testosterone Undecanoate

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

A Study of Vemurafenib in Participants With Metastatic Melanoma

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness